Asia Pharmaceuticals Market Research Reports - Data on Pharmaceuticals in Asia page 1

Printer Format

Region:	All Regions > Asia
Category:	All Categories > Life Sciences > Pharmaceuticals

(1762 reports matching your criteria)

Singapore Healthcare Industry 2H12 1/14/2013 \| published by: Emerging Markets Direct Reports ... centric initiative, and national electronic health records, plus the profile, comparative matrix and SWOT of the industry leading players: Parkway Holdings Ltd (Parkway), Thomson Medical Centre (TMC), Health Management International Ltd (HMI), and China Healthcare ... \| more... Search inside this report	$480.00
Indonesia Pharmaceuticals & Healthcare Industry 2H12 1/14/2013 \| published by: Emerging Markets Direct Reports ... support and pharmaceutical trade. It also covers the market trends and outlook, regulatory changes, counterfeit drugs, industry SWOT analysis and market outlook, plus profile, comparative matrix and SWOT analysis of the leading players: PT Kalbe ... \| more... Search inside this report	$450.00
OTC Medications – Russia – a snapshot (2012) 1/2/2013 \| published by: Mintel - Snapshots ... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Russia is given in RUB with a minimum ... \| more... Search inside this report	$600.00
Vitamins & Minerals – Russia – a snapshot (2012) 1/2/2013 \| published by: Mintel - Snapshots ... prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in Russia is given in RUB with a minimum of five years' ... \| more... Search inside this report	$600.00
Global Markets for Diabetes Therapeutics and Diagnostics - Focus on Asia 1/1/2013 \| published by: BCC Research ... Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017 Identification of markets based on epidemiological data and projections, plus information on R&D ... \| more...	$3,900.00
Kazakhstan Pharmaceuticals and Healthcare Report Q1 2013 12/26/2012 \| published by: Business Monitor International ... logistical challenges. In the short term, Kazakhstan's marketdevelopment is driven by a balanced policy of import substitution and integration into regional (CustomsUnion) and global (World Trade Organisation) systems. Over the longer term, the country could ... \| more...	$1,175.00
Research Report on China's Diabetes Drug Market, 2013-2017 12/26/2012 \| published by: China Research and Intelligence Co., Ltd. ... various pathogenic factors such as genetic factors, immune disorders, microbial infections and their toxins, free radical toxins, psychological factors on body. In recent years, with the development of China's economy and improvement in people's living ... \| more...	$2,800.00
Research Report on China's Antidepressant Market, 2013-2017 12/26/2012 \| published by: China Research and Intelligence Co., Ltd. ... million people commit suicide every year because of depression. Depression becomes a health crisis worldwide. Depression (also DEP) is a set of mood disorders or affective disorders with the main symptom of depression caused by ... \| more...	$2,800.00
Research Report on China's Antifungal Drug Market, 2013-2017 12/26/2012 \| published by: China Research and Intelligence Co., Ltd. ... tend to gradually increase in China, which is related to following factors to a certain extent: (1)Patients in hospital for a long term caused by severe basic diseases or lots of combined diseases will reduce ... \| more...	$2,800.00
Hong Kong Pharmaceuticals and Healthcare Report Q1 2013 12/26/2012 \| published by: Business Monitor International ... comparison to regional peers such as Singapore, Taiwan,China and South Korea means that the attractiveness of the market will dwindle over the longer term,should other developing countries such as Indonesia, Malaysia and the Philippines succeed ... \| more...	$1,175.00
Japan Pharmaceuticals and Healthcare Report Q1 2013 12/26/2012 \| published by: Business Monitor International ... and will seek to save costs through the use of more genericdrugs and price cuts. Nevertheless, the current profile broods well for generic drugmakers as well ascompanies focusing on eldercare and chronic disease management. Headline ... \| more...	$1,175.00
Taiwan Pharmaceuticals and Healthcare Report Q1 2013 12/26/2012 \| published by: Business Monitor International ... Generation National Health Insurance (NHI) programme, whichbecomes effective in 2013, a new reimbursement system is expected to be rolled out in Taiwan. TheAmerican Chamber of Commerce in Taipei (AmCham), in its latest White Paper published ... \| more...	$1,175.00
Vitamins & Minerals – China – a snapshot (2012) 12/20/2012 \| published by: Mintel - Snapshots ... prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in China is given in CNY with a minimum of five years' ... \| more... Search inside this report	$600.00
OTC Medications – China – a snapshot (2012) 12/18/2012 \| published by: Mintel - Snapshots ... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in China is given in CNY with a minimum ... \| more... Search inside this report	$600.00
Research Report on China's Antithrombotic Drug Market, 2013-2017 12/14/2012 \| published by: China Research and Intelligence Co., Ltd. ... primary reason for incidence and death of cardiovascular diseases, which is also one of the important causes for death of cancer patients. Nowadays, cardiac-cerebral thrombotic diseases (stroke and myocardial infarction) are severely threatening the life ... \| more...	$2,400.00
Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 12/12/2012 \| published by: GlobalData ... data on the Respiratory Devices market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within six market categories – Ventilators, Positive Airway ... \| more... Search inside this report	$2,500.00
Thailand Pharmaceuticals and Healthcare Report Q1 2013 12/12/2012 \| published by: Business Monitor International ... issues such as the shortage of medical professionals and hospital overcrowding, given that theseproblems existed when the scheme was first implemented. We highlight that universal healthcarecoverage will prove to be financially unsustainable in the long ... \| more...	$1,175.00
Turkey Pharmaceuticals and Healthcare Report Q1 2013 12/12/2012 \| published by: Business Monitor International ... various insuranceand immunisation schemes. Price cutting and public discount decrees announced in November 2011continue to affect the pharmaceutical market in 2012, as highlighted by the decrease in pharmaceuticalspending in the first half of this year. ... \| more...	$1,175.00
Airway and Anesthesia Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 12/12/2012 \| published by: GlobalData ... 2018” provides key market data on the Airway and Anesthesia Devices market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within six ... \| more... Search inside this report	$2,500.00
China Chinese Prepared Medicines Market Report 12/12/2012 \| published by: Beijing Zeefer Consulting Ltd. ... chinese prepared medicines market size and market share in China, the study on major hot areas in this market, introduction of key data and the comparison of major 10 enterprises in terms of sales revenue ... \| more... Search inside this report	$680.00
Pakistan Pharmaceuticals and Healthcare Report Q1 2013 12/12/2012 \| published by: Business Monitor International ... professionals to effectively monitor the costly andtimely process, while patients would benefit from more rapidly introduced pharmaceuticals. Drugmakerswould also see higher commercial upside if the requirements were withdrawn. Headline Expenditure Projections Pharmaceuticals: PKR171.20bn (US$1.98bn) in ... \| more...	$1,175.00
Vitamins & Minerals – India – a snapshot (2012) 12/6/2012 \| published by: Mintel - Snapshots ... prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in India is given in INR with a minimum of five years' ... \| more... Search inside this report	$600.00
Vitamins & Minerals – Japan – a snapshot (2012) 12/3/2012 \| published by: Mintel - Snapshots ... prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in Japan is given in JPY with a minimum of five years' ... \| more... Search inside this report	$600.00
Vitamins & Minerals – Thailand – a snapshot (2012) 12/3/2012 \| published by: Mintel - Snapshots ... prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in Thailand is given in THB with a minimum of five years' ... \| more... Search inside this report	$600.00
OTC Medications – Malaysia – a snapshot (2012) 12/3/2012 \| published by: Mintel - Snapshots ... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Malaysia is given in MYR with a minimum ... \| more... Search inside this report	$600.00

< prev 1 2 3 4 5 6 7 8 9 10 next >

Matching Categories

Matching geography

Research assistance

Join Alert Me now!